Skip to content
US | INTERNATIONAL
Ablative_Solutions_tlogo
  • Home
  • Public
    • About HTN
  • Health Care Providers
    • Sympathetic Nerves
    • Peregrine Catheter
    • TARGET BP Clinical Program
  • About
    • Company
    • Leadership
    • Patents
  • Media
  • Contact Us
    • Careers
×
  • Home
  • Public
    • About HTN
  • Health Care Providers
    • Sympathetic Nerves
    • Peregrine Catheter
    • TARGET BP Clinical Program
  • About
    • Company
    • Leadership
    • Patents
  • Media
  • Contact Us
    • Careers
Ablative_Solutions_mobile_logo
  • Home
  • Public
    • About HTN
  • Health Care Providers
    • Sympathetic Nerves
    • Peregrine Catheter
    • TARGET BP Clinical Program
  • About
    • Company
    • Leadership
    • Patents
  • Media
  • Contact Us
    • Careers
×
  • Home
  • Public
    • About HTN
  • Health Care Providers
    • Sympathetic Nerves
    • Peregrine Catheter
    • TARGET BP Clinical Program
  • About
    • Company
    • Leadership
    • Patents
  • Media
  • Contact Us
    • Careers

Resources

Check out these resources to improve your knowledge about high blood pressure.

logo-esh
European Society of Hypertension
logo-who
World Health Organization
Ablative_Solutions_flogo
  • Media
  • Resources
  • Contact Us
  • Careers
  • Leadership

©2025 Ablative Solutions, Inc. | info@ablativesolutions.com | Privacy Notice | Terms & Conditions

CAUTION: The Peregrine System Kit is an investigational product that is currently being studied to evaluate safety and efficacy when used in the treatment of patients with uncontrolled hypertension and is limited to investigation use in clinical trials.

The Peregrine System™ Infusion Catheter (Peregrine Catheter) has received CE Mark approval and is available in two models. The Peregrine Catheter 4-7 mm is intended for use in vessels having an inner diameter of 4-7 mm and the Peregrine Catheter 3-4 mm is intended for use in vessels having an inner diameter of 3-4 mm. The Peregrine System Infusion Catheter is intended for the infusion of a neurolytic agent (such as dehydrated alcohol, also referred to as alcohol) to achieve a reduction in systemic blood pressure in hypertensive patients.

Cookies
To make this site work properly, we sometimes place small data files called cookies on your device. Most big websites do this too.
Accept
Read more

Alert

You are leaving the International website. The content of the website you are seeking to access is specific to that region and may contain information that is not applicable to your region. Do you wish to continue?